MAISON BURR-MELDRUM: Open Payments
NPI 1033953773 · MARYSVILLE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,857 in 100 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $392 · 2025 $1,857
Food & beverage: $1,857
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $313 |
| Vanda Pharmaceuticals Inc. | 12 | $273 |
| Novo Nordisk Inc | 13 | $229 |
| ABBVIE INC. | 14 | $194 |
| Lilly USA, LLC | 10 | $145 |
| Otsuka America Pharmaceutical, Inc. | 5 | $101 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $79 |
| Axsome Therapeutics, Inc. | 4 | $77 |
| Amgen Inc. | 4 | $62 |
| PFIZER INC. | 3 | $58 |
Products named: FANAPT, Wegovy, VRAYLAR, AIRSUPRA, FARXIGA, REXULTI, MOUNJARO, XIFAXAN.
Industry payments across MI — which companies pay providers there.
